Item 5.07 Submission of Matters to a Vote of Security Holders On December 26, INVO Bioscience, Inc. held its 2023 annual meeting of shareholders . A total of 952,082.
Form S-1/A Netcapital Inc streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
INVO Bioscience, Inc. (NASDAQ:NASDAQ:INVO) Q1 2022 Earnings Conference Call May 16, 2022, 04:30 PM ET Company Participants Robert Blum - Lytham Partners, LLC, IR Steven Shum - CEO Michael.